214 related articles for article (PubMed ID: 24691433)
1. Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms.
Kota DJ; DiCarlo B; Hetz RA; Smith P; Cox CS; Olson SD
Sci Rep; 2014 Apr; 4():4565. PubMed ID: 24691433
[TBL] [Abstract][Full Text] [Related]
2. TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.
Rashedi I; Gómez-Aristizábal A; Wang XH; Viswanathan S; Keating A
Stem Cells; 2017 Jan; 35(1):265-275. PubMed ID: 27571579
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles.
Hwang S; Sung DK; Kim YE; Yang M; Ahn SY; Sung SI; Chang YS
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003458
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of human adipose-derived mesenchymal stromal cell Toll-like receptor priming and effects on interaction with prostate cancer cells.
Rivera-Cruz CM; Figueiredo ML
Cytotherapy; 2023 Jan; 25(1):33-45. PubMed ID: 36257875
[TBL] [Abstract][Full Text] [Related]
5. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.
Waterman RS; Tomchuck SL; Henkle SL; Betancourt AM
PLoS One; 2010 Apr; 5(4):e10088. PubMed ID: 20436665
[TBL] [Abstract][Full Text] [Related]
6. A Study of the Immunoregulatory Function of TLR3 and TLR4 on Mesenchymal Stem Cells in Ankylosing Spondylitis.
Li Y; Huang L; Cai Z; Deng W; Wang P; Su H; Wu Y; Shen H
Stem Cells Dev; 2019 Oct; 28(20):1398-1412. PubMed ID: 31456484
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
[TBL] [Abstract][Full Text] [Related]
9. Netrin-1 prolongs skin graft survival by inducing the transformation of mesenchymal stem cells from pro-rejection to immune-tolerant phenotype.
Liu LP; Chen W; Fan Y; Qi BY; Wang Z; Shi BY
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8741-8750. PubMed ID: 31696460
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
[TBL] [Abstract][Full Text] [Related]
11. Left Ventricular Dysfunction Switches Mesenchymal Stromal Cells Toward an Inflammatory Phenotype and Impairs Their Reparative Properties Via Toll-Like Receptor-4.
Naftali-Shani N; Levin-Kotler LP; Palevski D; Amit U; Kain D; Landa N; Hochhauser E; Leor J
Circulation; 2017 Jun; 135(23):2271-2287. PubMed ID: 28356441
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
13. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.
Romieu-Mourez R; François M; Boivin MN; Bouchentouf M; Spaner DE; Galipeau J
J Immunol; 2009 Jun; 182(12):7963-73. PubMed ID: 19494321
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.
van den Akker F; de Jager SC; Sluijter JP
Mediators Inflamm; 2013; 2013():181020. PubMed ID: 24391353
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
Front Immunol; 2018; 9():2538. PubMed ID: 30473695
[TBL] [Abstract][Full Text] [Related]
16. The role of Toll-like receptor 3 and 4 in regulating the function of mesenchymal stem cells isolated from umbilical cord.
Zhang L; Liu D; Pu D; Wang Y; Li L; He Y; Li Y; Li L; Qiu Z; Zhao S; Li W
Int J Mol Med; 2015 Apr; 35(4):1003-10. PubMed ID: 25695694
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stromal Cells Rapidly Suppress TCR Signaling-Mediated Cytokine Transcription in Activated T Cells Through the ICAM-1/CD43 Interaction.
Zheng S; Huang K; Xia W; Shi J; Liu Q; Zhang X; Li G; Chen J; Wang T; Chen X; Xiang AP
Front Immunol; 2021; 12():609544. PubMed ID: 33692786
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms.
Teo GS; Ankrum JA; Martinelli R; Boetto SE; Simms K; Sciuto TE; Dvorak AM; Karp JM; Carman CV
Stem Cells; 2012 Nov; 30(11):2472-86. PubMed ID: 22887987
[TBL] [Abstract][Full Text] [Related]
19. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury.
Abarbanell AM; Wang Y; Herrmann JL; Weil BR; Poynter JA; Manukyan MC; Meldrum DR
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1529-36. PubMed ID: 20173040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]